Free Trial

Westwood Holdings Group Inc. Purchases New Stake in Grail, Inc. (NASDAQ:GRAL)

Grail logo with Medical background

Westwood Holdings Group Inc. acquired a new position in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 77,789 shares of the company's stock, valued at approximately $1,389,000. Westwood Holdings Group Inc. owned 0.23% of Grail as of its most recent SEC filing.

Several other large investors also recently modified their holdings of GRAL. Lindbrook Capital LLC acquired a new stake in shares of Grail during the fourth quarter worth $28,000. State of Tennessee Department of Treasury bought a new position in Grail during the fourth quarter worth $28,000. Sterling Capital Management LLC bought a new position in Grail during the fourth quarter worth $29,000. Wellington Shields Capital Management LLC bought a new position in Grail during the fourth quarter worth $33,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Grail during the fourth quarter worth $41,000.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on GRAL shares. Canaccord Genuity Group increased their target price on shares of Grail from $32.00 to $43.00 and gave the stock a "buy" rating in a research note on Wednesday, May 14th. Morgan Stanley increased their target price on shares of Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a research note on Tuesday, March 18th.

Get Our Latest Stock Report on Grail

Grail Stock Up 3.6%

GRAL traded up $1.41 during trading on Friday, hitting $40.18. 779,087 shares of the company's stock were exchanged, compared to its average volume of 1,255,980. The business's 50 day moving average is $31.00 and its two-hundred day moving average is $27.43. Grail, Inc. has a fifty-two week low of $12.33 and a fifty-two week high of $63.99. The stock has a market cap of $1.45 billion and a P/E ratio of -0.66.

Grail (NASDAQ:GRAL - Get Free Report) last released its quarterly earnings data on Tuesday, May 13th. The company reported ($3.10) earnings per share for the quarter, topping the consensus estimate of ($4.03) by $0.93. The business had revenue of $31.84 million for the quarter, compared to analyst estimates of $35.80 million. On average, sell-side analysts forecast that Grail, Inc. will post -15.15 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Robert P. Ragusa sold 7,625 shares of the stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $31.21, for a total value of $237,976.25. Following the completion of the sale, the chief executive officer now owns 828,662 shares in the company, valued at $25,862,541.02. This represents a 0.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, President Joshua J. Ofman sold 2,109 shares of the stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $31.20, for a total transaction of $65,800.80. Following the completion of the sale, the president now owns 559,673 shares of the company's stock, valued at approximately $17,461,797.60. This represents a 0.38% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 194,948 shares of company stock worth $6,583,130. Insiders own 1.85% of the company's stock.

Grail Company Profile

(Free Report)

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.

See Also

Institutional Ownership by Quarter for Grail (NASDAQ:GRAL)

Should You Invest $1,000 in Grail Right Now?

Before you consider Grail, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.

While Grail currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

ACT FAST! Congress Is POURING Into This Stock
The Hottest AI Stock You Haven’t Bought Yet
This $13 Trillion Energy Breakthrough Will Make Millionaires

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines